Replies to post #3426 on Nutra Pharma Corp (NPHC)

[stayfocused]

I agree, the positives far outweigh any negatives.

I think by EOY 2010 we will see OTC sales of 2-3m units per month at $2.50 net earnings so that equates to $90m NET earnings, they say they need to raise $100m for MS phases so even if the O/S becomes 400m that means an EPS of .22, that is just OTC. We also have prescription Nyloxin that could dwarf those figures and then there's the speculation on the MS phase 1 study, I mean pick a number? Personally speaking I don't think 5 bucks is too strange a target for 2010. JMO